Allos Therapeutics (ALTH) Granted FDA Orphan Drug Designation for Treatment of Patients with Follicular Lymphoma
Tweet Send to a Friend
Allos Therapeutics, Inc. (Nasdaq: ALTH) today announced that the U.S. FDA ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
